- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| SS INNOVATIONS INTERNATIONAL Aktie jetzt für 0€ handeln | |||||
| Di | SS Innovations International: CEO-Interview auf NASDAQ veröffentlicht | 2 | Investing.com Deutsch | ||
| Di | SS Innovations International, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 08.12. | SS Innovations submits Mantra surgical robot to FDA for clearance | 2 | MassDevice | ||
| 08.12. | SS Innovations submits FDA 510(k) for surgical robotic system | 1 | Investing.com | ||
| 08.12. | SS Innovations Submits 510(k) Premarket Notification to the FDA for the Company's SSi Mantra Surgical Robotic System | 95 | GlobeNewswire (Europe) | -- Submission covers multiple indications including general, urological, colorectal, gynecological and cardiac surgeries -- FORT LAUDERDALE, Fla., Dec. 08, 2025 (GLOBE NEWSWIRE) -- SS Innovations... ► Artikel lesen | |
| 08.12. | SS Innovations International, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 06.11. | SS Innovations reports first telesurgery with new surgeon console | 1 | MassDevice | ||
| 06.11. | SS Innovations completes first telesurgery with new compact console | 1 | Investing.com | ||
| 06.11. | SS Innovations Announces Successful Completion of First Telesurgery Performed with the Company's SSi Mantra Tele Surgeon Console | 143 | GlobeNewswire (Europe) | FORT LAUDERDALE, Fla., Nov. 06, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the "Company" or "SS Innovations") (Nasdaq: SSII), a developer of innovative surgical robotic technologies... ► Artikel lesen | |
| 06.11. | SS Innovations International, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 28.10. | SS Innovations International GAAP EPS of -$0.02, revenue of $12.8M | 1 | Seeking Alpha | ||
| 28.10. | SS Innovations International, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 28.10. | SS Innovations International, Inc. - 10-Q, Quarterly Report | 14 | SEC Filings | ||
| 28.10. | SS Innovations Reports Third Quarter 2025 Financial Results | 111 | GlobeNewswire (Europe) | FORT LAUDERDALE, Fla., Oct. 28, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the "Company" or "SS Innovations") (Nasdaq: SSII), a developer of innovative surgical robotic technologies... ► Artikel lesen | |
| 21.10. | SS Innovations International, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 14.10. | SS Innovations International, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 03.10. | SS Innovations International, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 02.10. | SS Innovations is set to submit its surgical robot to the FDA | 4 | MassDevice | ||
| 02.10. | SS Innovations completes key study for surgical robot FDA submission | 1 | Investing.com | ||
| 02.10. | SS Innovations Provides U.S. Regulatory Update for the SSi Mantra Surgical Robotic System | 183 | GlobeNewswire (Europe) | Company successfully completed a human factors validation study at Johns Hopkins Hospital Anticipates submitting a 510(k) premarket notification to the FDA in the fourth quarter of 2025 FORT LAUDERDALE... ► Artikel lesen |
1 2 3 Weiter >>
51 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDLINE | 40,450 | 0,00 % | Aktien New York: Nasdaq schwach nach starkem Jahr - Medline-Börsengang im Blick | NEW YORK (dpa-AFX) - Die US-Börsen haben am Mittwoch erneut nachgegeben. Die Wall Street und vor allem die technologielastige Nasdaq zollten ihrem starken Lauf im Jahr 2025 weiter Tribut. Sorgen über... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 35,590 | 0,00 % | BrightSpring upgraded at KeyBanc on specialty pharmacy and EBITDA prospects | ||
| HEARTBEAM | 3,060 | 0,00 % | Heartbeam stock is a buy, this analyst says | ||
| PROGYNY | 26,010 | 0,00 % | Progyny, Inc. - 8-K, Current Report | ||
| ALIGNMENT HEALTHCARE | 20,550 | 0,00 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 44,510 | -0,29 % | BERNSTEIN RESEARCH stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat Siemens Healthineers mit "Outperform" und einem Kursziel von 52,90 Euro in die Bewertung wieder aufgenommen. Nach einem für die... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,200 | -0,25 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| BETA BIONICS | 29,200 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| FRESENIUS | 47,860 | +0,17 % | JPMORGAN stuft Fresenius SE auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Fresenius mit einem Kursziel von 53,60 Euro auf "Overweight" belassen. Die Veranstaltung mit dem Biopharma-Management der Bad... ► Artikel lesen | |
| GENEDX | 135,46 | 0,00 % | GeneDx and Guardant Health named as BTIG's top picks for 2026 | ||
| PROCEPT BIOROBOTICS | 33,780 | 0,00 % | UBS stuft Procept BioRobotics mit "Buy" ein - Wachstum bei Systemauslastung als Treiber | ||
| RXSIGHT | 12,620 | 0,00 % | Pre-market Movers: Basel Medical Group, SOBR Safe, ProKidney, RxSight, Mustang Bio | OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green Basel Medical Group Ltd (BMGL) is up over 88% at... ► Artikel lesen | |
| NUTEX HEALTH | 159,17 | 0,00 % | Nutex Health, Inc.: Nutex Health Responds To Short Seller Report | HOUSTON, Nov. 26, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), is aware of a short seller report issued on November... ► Artikel lesen | |
| CLEARPOINT NEURO | 13,550 | 0,00 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Completes Acquisition of IRRAS | Acquisition Will Enhance ClearPoint Neuro's Commercial Scale, Drive Operational Leverage, and Support Its Long-Term Strategy in CNS Drug Delivery Innovation SOLANA BEACH, CALIFORNIA / ACCESS Newswire... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 6,915 | +0,51 % | LifeStance Health Group, Inc.: LifeStance Reports Third Quarter 2025 Results | SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen |
SS INNOVATIONS INTERNATIONAL INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 4,800 Euro und damit -0,41 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SS INNOVATIONS INTERNATIONAL INC finden Sie auf Wallstreet Online.